Market Cap: $31.33B
DI
DexCom, Inc.
DXCM
NASDAQ (NASDAQ Global Select)USD
Market Cap: $31.33B
Dexcom (Ticker: DXCM) is actively working to enhance diabetes management tools, with a focus on the newly redesigned Stelo app that will launch in July. This initiative aims to provide users with more…
Dexcom (Ticker: DXCM) embarks on a major expansion of its continuous glucose monitoring technology with the recent approval of its Stelo Glucose Biosensor System by the U.S. Food and Drug Administrati…
In a significant advancement for diabetes management among children, Dexcom (Ticker: DXCM) continues to solidify its role in the continuous glucose monitoring (CGM) space. The recent FDA approval of S…
Dexcom (Ticker: DXCM) announces significant developments in diabetes management at the American Diabetes Association’s Scientific Sessions. The company unveils promising results from its CONNECT trial…
DexCom, a leader in continuous glucose monitoring technology (Ticker: DXCM), introduces notable governance changes as it gears up for its 2026 Investor Day, marking a significant evolution in its oper…
DexCom leverages a significant shift in the insurance reimbursement landscape, looking to capitalize on expanded coverage for its continuous glucose monitoring (CGM) systems. This recent development a…
Dexcom Charts Path Toward FDA Approval with Innovative Device Studies Dexcom takes significant strides in the medical device landscape by announcing its plan to submit an Investigational Device Exempt…
Dexcom Advances Continuous Glucose Monitoring Technology Amid Competitive Landscape Dexcom, a leader in continuous glucose monitoring (CGM) technology, continues to strengthen its position in the diab…
Dexcom Navigates Diverse Analyst Sentiment Amidst Competitive Landscape In recent months, Dexcom, Inc. (NASDAQ:DXCM) finds itself under the scrutiny of market analysts who provide a spectrum of foreca…
Dexcom Faces Investigation Over Potential Breaches of Fiduciary Duty Halper Sadeh LLC, a law firm specializing in investor rights, is currently investigating potential fiduciary duty breaches by offic…
Dexcom Faces Legal Scrutiny Over Governance Practices In a developing situation, Halper Sadeh LLC, a law firm specializing in investor rights, initiates an investigation into potential breaches of fid…
Dexcom pins 2026 growth on rising CGM adoption and device integrations Dexcom reports a fourth-quarter adjusted earnings beat and reiterates its 2026 revenue guidance, signaling continuing demand for…
Diabetes device demand faces a test as U.S. jobs and inflation data arrive together next week, potentially reshaping the funding and purchasing environment for continuous glucose monitors (CGMs) maker…
Dexcom Under Legal Scrutiny for Potential Governance Issues Dexcom, Inc., a leader in continuous glucose monitoring systems, faces an investigation by Halper Sadeh LLC, a New York-based law firm speci…
Dexcom Faces Class Action Lawsuit Over Alleged Device Reliability Issues Dexcom, Inc., a leader in continuous glucose monitoring technology, is now embroiled in a class action securities lawsuit filed…
DexCom Faces Legal Scrutiny Over Allegations of Misleading Product Changes DexCom, Inc. is currently under scrutiny as multiple law firms announce class action lawsuits concerning alleged misleading p…
Dexcom Faces Class Action Lawsuit Over Alleged Product Reliability Issues Dexcom, Inc., a leader in continuous glucose monitoring systems, is currently embroiled in a class action securities lawsuit i…
Dexcom Under Legal Scrutiny Over Alleged Misleading Practices in Glucose Monitoring Systems Dexcom, a leader in continuous glucose monitoring technology, faces potential legal challenges as a class ac…
Dexcom's Innovative Approach to Continuous Glucose Monitoring Dexcom, a leader in continuous glucose monitoring (CGM) technology, continues to redefine diabetes management through its innovative produ…
Dexcom's Position in the Health-Tech Landscape Amid Market Speculation In recent discussions surrounding stock performance and investment strategies, Dexcom finds itself under scrutiny within the heal…
Dexcom Faces Legal Scrutiny Over Allegations of Compromised Device Reliability Dexcom, Inc. finds itself at the center of a legal storm as Rosen Law Firm announces a class action lawsuit against the c…
Dexcom's Leadership in Diabetes Management: A Commitment to Innovation and Growth Dexcom, a prominent player in the diabetes management industry, showcases a remarkable track record of financial perfo…
Dexcom's Commitment to Innovation in Diabetes Management Under Scrutiny Dexcom, a prominent player in the diabetes management industry, continues to solidify its leadership position with its advanced…
Dexcom Faces Legal Scrutiny Over Potential Governance Breaches Dexcom, Inc. is currently under investigation by Halper Sadeh LLC, a New York-based investor rights law firm, for potential breaches of f…
Dexcom Faces Class Action Lawsuits Over Alleged Misleading Statements Dexcom, Inc. finds itself at the center of multiple class action lawsuits alleging serious violations of the Securities Exchange A…
Dexcom Faces Legal Challenges Amid Allegations of Misleading Statements Dexcom, Inc., a leader in continuous glucose monitoring systems, is currently embroiled in legal difficulties following two clas…
Dexcom Under Legal Scrutiny for Potential Governance Failures Dexcom, Inc., a leader in continuous glucose monitoring systems, faces increasing scrutiny from investor rights law firms regarding potent…
### Dexcom Faces Legal Scrutiny Over Continuous Glucose Monitoring Systems In a significant development for Dexcom, Inc., a law firm specializing in investor rights, Halper Sadeh LLC, initiates an inv…
Dexcom Faces Scrutiny Amid Allegations of Misleading Product Claims Dexcom, Inc. finds itself under intense scrutiny as multiple law firms investigate potential securities fraud claims stemming from a…
### Dexcom Faces Class Action Lawsuits Over Alleged Misleading Practices Dexcom, Inc., a leader in continuous glucose monitoring systems, is embroiled in legal challenges following the announcement of…
Dexcom Faces Legal Scrutiny Over Allegations of Misleading Practices in Glucose Monitoring Systems Dexcom, Inc., a leading player in continuous glucose monitoring (CGM) technology, is currently embroi…
Dexcom Faces Class Action Lawsuits Amid Allegations of Misleading Statements Dexcom, Inc., a leading player in continuous glucose monitoring technology, is currently embroiled in multiple class action…
Dexcom Faces Legal Scrutiny Over Glucose Monitoring System Allegations Dexcom, Inc., a leader in continuous glucose monitoring (CGM) technology, currently navigates a challenging legal landscape as Ro…
Dexcom Faces Legal Challenges Over Alleged Misrepresentation of Glucose Monitoring Devices Dexcom, Inc. is currently navigating significant legal challenges stemming from allegations of unauthorized d…
Dexcom Faces Legal Challenges Over Alleged Misleading Practices Dexcom, Inc., a leader in continuous glucose monitoring systems, finds itself embroiled in legal disputes following the announcement of…
DexCom Faces Class Action Lawsuit Over Allegations of Misleading Statements DexCom, Inc., a leading developer of continuous glucose monitoring (CGM) systems, is embroiled in legal challenges stemming…
DexCom Faces Legal Challenges Over Continuous Glucose Monitoring Systems DexCom, a leading medical device company specializing in continuous glucose monitoring (CGM) systems for diabetes management, i…
Dexcom Faces Class Action Lawsuit Amid Allegations of Misleading Statements Dexcom, Inc. is currently embroiled in a class action lawsuit initiated by the Schall Law Firm, which claims the company has…
Dexcom Faces Class Action Lawsuit Over Allegations of Misleading Product Information Dexcom, Inc., a leading player in the glucose monitoring industry, is currently embroiled in potential legal troubl…
Dexcom Faces Class Action Lawsuit Over Alleged Device Misrepresentations On November 4, 2025, the Rosen Law Firm announces a class action lawsuit against DexCom, Inc. (NASDAQ: DXCM) concerning the com…
Dexcom Faces Legal Challenges Over Alleged Misrepresentation of Product Reliability and Financial Performance Dexcom, Inc., a key player in the continuous glucose monitoring market, finds itself under…
Dexcom's Growth Amidst a Dynamic Market Landscape Dexcom, Inc. (NASDAQ:DXCM) reports remarkable financial results for the third quarter of 2025, achieving revenues of $1.209 billion, surpassing analys…
Dexcom's Positive Shift in Investor Sentiment Amid Market Volatility In recent developments, DexCom Inc. experiences a noteworthy decline in short interest, marking a significant change in investor se…
Dexcom Faces Scrutiny Over G7 Continuous Glucose Monitor Following Fatalities Dexcom Inc., a leader in continuous glucose monitoring technology, is currently navigating a challenging period following…
Dexcom Advances in Diabetes Management Amid Industry Shifts Dexcom, a leader in continuous glucose monitoring (CGM) systems, continues to navigate a rapidly evolving healthcare landscape. With the inc…
Dexcom's Position in Diabetes Care: Navigating Innovation and Competition In the ever-evolving landscape of diabetes management, Dexcom stands out as a leader in the development of continuous glucose…
Dexcom's Position in Diabetes Management: A Mixed Perspective from Analysts Dexcom continues to be a pivotal player in the diabetes management sector, particularly with its cutting-edge continuous glu…
Dexcom's Innovation in Diabetes Management Amid Economic Uncertainty In a landscape marked by economic fluctuations and uncertainty, Dexcom continues to solidify its position as a leader in diabetes m…
Dexcom's Focus on Innovation Amid Broader Economic Concerns As the healthcare technology industry continues to evolve, Dexcom stands out with its commitment to developing continuous glucose monitoring…
Dexcom’s Focus on Innovation in Diabetes Management Dexcom, a leader in continuous glucose monitoring (CGM) technology, continues to push the boundaries of diabetes management with its commitment to i…